Saratoga Research & Investment Management Johnson & Johnson Transaction History

Saratoga Research & Investment Management

$2.2 Billion
Q2 2024

A detailed history of Saratoga Research & Investment Management transactions in Johnson & Johnson stock. As of the latest transaction made, Saratoga Research & Investment Management holds 551,753 shares of JNJ stock, worth $91 Million. This represents 3.67% of its overall portfolio holdings.

Number of Shares

551,753

Previous 439,519 25.54%

Holding current value

$91 Million

Previous $69.5 Million 15.99%

% of portfolio

3.67%

Previous 3.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	BUY	$144.38 - $157.78 $16.2 Million - $17.7 Million	112,234 Added 25.54%	551,753 $80.6 Million
Q1 2024 Apr 17, 2024	BUY	$155.22 - $162.74 $679,397 - $712,312	4,377 Added 1.01%	439,519 $69.5 Million
Q4 2023 Feb 09, 2024	SELL	$145.6 - $158.88 $3.12 Million - $3.41 Million	-21,444 Reduced 4.7%	435,142 $68.2 Million
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $286,424 - $320,868	-1,839 Reduced 0.4%	456,586 $71.1 Million
Q2 2023 Jul 24, 2023	BUY	$154.35 - $166.11 $2.78 Million - $2.99 Million	18,016 Added 4.09%	458,425 $75.9 Million
Q1 2023 May 05, 2023	BUY	$151.05 - $180.26 $5.5 Million - $6.56 Million	36,389 Added 9.01%	440,409 $68.3 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $1.99 Million - $2.23 Million	-12,419 Reduced 2.98%	404,020 $71.4 Million
Q3 2022 Oct 31, 2022	BUY	$161.33 - $179.52 $5.71 Million - $6.36 Million	35,409 Added 9.29%	416,439 $68 Million
Q2 2022 Aug 01, 2022	SELL	$168.19 - $186.01 $3.19 Million - $3.53 Million	-18,982 Reduced 4.75%	381,030 $67.6 Million
Q1 2022 Apr 29, 2022	SELL	$158.14 - $179.59 $181,386 - $205,989	-1,147 Reduced 0.29%	400,012 $70.9 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $711,196 - $789,098	4,561 Added 1.15%	401,159 $68.6 Million
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $1.51 Million - $1.67 Million	9,331 Added 2.41%	396,598 $64.1 Million
Q2 2021 Aug 10, 2021	BUY	$159.48 - $171.07 $431,074 - $462,402	2,703 Added 0.7%	387,267 $63.8 Million
Q1 2021 Apr 12, 2021	BUY	$153.07 - $170.48 $5.69 Million - $6.34 Million	37,192 Added 10.71%	384,564 $63.2 Million
Q4 2020 Feb 03, 2021	BUY	$137.11 - $157.38 $2.64 Million - $3.03 Million	19,240 Added 5.86%	347,372 $54.7 Million
Q3 2020 Oct 09, 2020	SELL	$140.38 - $153.83 $352,634 - $386,420	-2,512 Reduced 0.76%	328,132 $48.9 Million
Q2 2020 Aug 07, 2020	BUY	$128.81 - $155.51 $926,787 - $1.12 Million	7,195 Added 2.22%	330,644 $46.5 Million
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $11.8 Million - $16.4 Million	106,284 Added 48.94%	323,449 $42.4 Million
Q4 2019 Feb 05, 2020	SELL	$127.5 - $146.44 $16,447 - $18,890	-129 Reduced 0.06%	217,165 $31.7 Million
Q3 2019 Oct 29, 2019	SELL	$126.95 - $142.14 $287,795 - $322,231	-2,267 Reduced 1.03%	217,294 $28.1 Million
Q2 2019 Jul 24, 2019	BUY	$131.15 - $144.24 $390,302 - $429,258	2,976 Added 1.37%	219,561 $30.6 Million
Q1 2019 Apr 18, 2019	BUY	$125.72 - $139.79 $32,058 - $35,646	255 Added 0.12%	216,585 $30.3 Million
Q4 2018 Jan 15, 2019	SELL	$122.84 - $147.84 $1.67 Million - $2.01 Million	-13,562 Reduced 5.9%	216,330 $27.9 Million
Q3 2018 Oct 15, 2018	SELL	$121.58 - $142.88 $1.01 Million - $1.19 Million	-8,326 Reduced 3.5%	229,892 $31.8 Million
Q2 2018 Jul 17, 2018	SELL	$119.4 - $131.76 $1.68 Million - $1.85 Million	-14,056 Reduced 5.57%	238,218 $28.9 Million
Q1 2018 May 01, 2018	SELL	$125.1 - $148.14 $110,338 - $130,659	-882 Reduced 0.35%	252,274 $32.3 Million
Q4 2017 Jan 19, 2018	SELL	$131.22 - $143.62 $719,872 - $787,899	-5,486 Reduced 2.12%	253,156 $35.4 Million
Q3 2017 Oct 24, 2017	BUY	$129.47 - $135.38 $33.1 Million - $34.6 Million	255,587 Added 8366.19%	258,642 $33.6 Million
Q3 2017 Oct 24, 2017	BUY	$129.47 - $135.38 $395,530 - $413,585	3,055	3,055 $397,000

Others Institutions Holding JNJ

# of Institutions

4,158

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saratoga Research & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Saratoga Research & Investment Management with notifications on news.

Account

Saratoga Research & Investment Management Johnson & Johnson Transaction History